AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

GE Healthcare announces licensing agreements for green fluorescent protein access.

Asia Africa Intelligence Wire

| September 01, 2004 | COPYRIGHT 2004 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Australasian Biotechnology)

Bristol-Myers Squibb and Regeneron Pharmaceuticals Inc each have formed licensing agreements with GE Healthcare for rights to Aequorea Victoria Green Fluorescent Protein (AvGFP). The agreement will allow Bristol-Myers Squibb to use GFP in conducting primary and secondary screening, ...

Related articles from newspapers, magazines, journals, and more
Aurora Biosciences Announces Issuance of Second U.S. Patent for Improved Green...
Press release article from: PR Newswire August 12, 1998 700+ words
...colored mutants of Green Fluorescent Protein ("GFP...well. Mutants of green fluorescent protein are widely...860 publications on green fluorescent protein to date...Lambert, Bristol-Myers Squibb, Eli Lilly and Company...
Aurora Announces Issuance of U.S. Patent for Improved Green Fluorescent...
Press release article from: Business Wire June 4, 1997 700+ words
...625,048 that relates to variants of Green Fluorescent Protein (GFP) having increased brightness...technologies accessed by Bristol-Myers Squibb and Eli Lilly and Company for functional...Biotechnology Licensing, Bristol-Myers Squibb. "We believe that Aurora's fluorescent...
Amersham Pharmacia Biotech and Aurora Biosciences Sign Agreement to...
Press release article from: Business Wire September 10, 2001 700+ words
...commercialize their combined Green Fluorescent Protein (GFP) technology...excitation, shines with a bright green fluorescent glow that can be used to track...American Home Products, Bristol-Myers Squibb, Cystic Fibrosis Foundation...
BRISTOL-MYERS SQUIBB FILES CLAIMS AGAINST CANADIAN COMPANY FOR...
Press release article from: PR Newswire July 5, 1995 700+ words
MONTREAL, July 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today issued the following: Bristol-Myers Squibb and Bristol-Myers Squibb Canada Inc. today announced they have filed further claims in...
BRISTOL-MYERS SQUIBB TAKES EQUITY POSITION IN IXSYS -- WILL FUND THREE-YEAR R&D...
Press release article from: PR Newswire June 30, 1993 700+ words
...PRNewswire/ -- Ixsys, Inc. and Bristol-Myers Squibb Pharmaceutical Group announced today...signed an agreement in which Bristol-Myers Squibb will take an equity position in Ixsys...million in funding and gives Bristol-Myers Squibb a slightly more than 9 percent equity...
Bristol-Myers Squibb Acquires Novel Oncology Drug From Manitoba Cancer...
Press release article from: PR Newswire September 5, 1996 700+ words
...Sept. 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY), the Manitoba...license agreement under which Bristol-Myers Squibb will develop and market DPPE, a novel...the terms of the agreement, Bristol-Myers Squibb, the world leader in cancer chemotherapy...
Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune...
Press release article from: PR Newswire November 30, 2007 700+ words
...children with HIV/AIDS, Bristol-Myers Squibb Company today joined Robert Wood Johnson...new clinical center at The Bristol-Myers Squibb Children's Hospital at Robert Wood...infectious diseases. The Bristol-Myers Squibb Pediatric Infectious Disease and Immunology...
Bristol-Myers Squibb and N.J. Governor Whitman Dedicate Hopewell Research and...
Press release article from: PR Newswire October 16, 1997 700+ words
...16 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) officials...executive officer of Bristol-Myers Squibb. "Today's dedication gives...occasion to reflect on Bristol-Myers Squibb's tradition of scientific excellence...
Bristol-Myers Squibb And Sanofi File In The U.S. And Europe For Approval Of New...
Press release article from: PR Newswire October 1, 1996 700+ words
...Oct. 1 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Sanofi announced...II receptor antagonists. "Bristol-Myers Squibb takes great pleasure in joining with...executive vice president, Bristol-Myers Squibb Company, and president, Bristol...
Bristol-Myers Squibb to Acquire Kosan Biosciences.
Press release article from: Business Wire May 29, 2008 700+ words
Bristol-Myers Squibb Advances Company Strategy with Latest...and HAYWARD, Calif. -- Bristol-Myers Squibb Company (NYSE: BMY) and Kosan Biosciences...therapeutics company, by Bristol-Myers Squibb, for $5.50 per share in cash...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA